Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford scientists form spinout to launch rapid COVID-19 virus test

The COVID-19 pandemic demands availability of highly accessible and rapid testing around the world to detect SARS-CoV-2 and enable countries to emerge from lockdown with confidence. Scientists from the University of Oxford’s Department of Engineering Science and Oxford Suzhou Centre for Advanced Research (OSCAR) have developed a rapid test which detects the presence of virus which could be adapted for use in settings ranging from community care, schools, airports or home self-testing.

Oxford COVID-19 study: face masks and coverings work – act now

Cloth face coverings, even homemade masks made of the correct material, are effective in reducing the spread of COVID-19 - for the wearer and those around them - according to a new study from Oxford’s Leverhulme Centre for Demographic Science.

Oxford University to lead a new national programme of AI research to improve lung cancer screening

UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.

Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19

In March 2020, the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including low-dose dexamethasone (a steroid treatment). Over 11,500 patients have been enrolled from over 175 NHS hospitals in the UK.

No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19

A new statement has been released from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine.

Expanding the immune system's arsenal to fend off viruses and cancer cells

Cytotoxic T lymphocytes (CTLs) kill infected and cancerous cells. Mike Dustin's team at the Kennedy Institute of Rheumatology, together with Roman Fischer and Benedikt Kessler from the Target Discovery Institute, NDM, detected transfer of cytotoxic multiprotein complexes from CTLs to target cells, termed supramolecular attack particles (SMAPs). SMAPs were rapidly released from CTLs and were autonomously cytotoxic.

Volunteer for COVID-19 studies at Oxford

We have a range of studies taking place at the moment, below are listed those that are still open for participants to take part in.

Six Oxford professors honoured by the Royal Society

Six Oxford University academics have been elected to the prestigious Fellowship of the Royal Society.

Landmark partnership announced for development of COVID-19 vaccine

The University of Oxford announced yesterday an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.

Results of remdesivir trial released

The results of a placebo-controlled trial of remdesivir in COVID-19 patients have been published in the Lancet.

Latest on Oxford's fight against COVID-19

22 Apr 2020 By Charvy Narain Much has changed since the beginning of the year, when University of Oxford researchers first started coming together to fight the novel coronavirus outbreak. But what has remained consistent is that the University of Oxford remains at the forefront of global efforts to combat the SARS-CoV-2 virus and mitigate its many effects: medical students have been stepping up, researchers with clinical skills are returning to front-line clinical roles, and others are offering up equipment and materials, as well as their laboratory skills to help the NHS respond to the crisis.

Oxford app helps avoid lockdown crowds

Keep safe, keep your distance – but keep on the go in the lockdown with Crowdless (crowdlessapp.co), a real-time app designed by an Oxford post-graduate student and other young entrepreneurs - and backed by the Oxford venture-supporting Foundry.

Researchers use virus genomic tracking to reveal the rise and fall of the COVID-19 epidemic in Guangdong Province

A new study led by researchers at Oxford and Guangdong Centre for Diseases Control and Prevention describes the epidemiology and genetic make-up of the COVID-19 outbreak in China’s most populous region, and shows how early and intensive testing and tracing helped to interrupt local transmission of the virus.

Global study to assess the effects of Covid-19 in pregnancy launched

Researchers at the University of Oxford are today starting a large, international study to evaluate the effects of Covid-19 in pregnancy. The INTERCOVID study will provide women, families, health care providers and policy makers with high-quality evidence regarding the effects of Covid-19 in pregnancy on the health of the mother, fetus and newborn.

Government collaboration to track Covid-19 in UK population launched

Researchers from the University of Oxford are supporting a new government study to track coronavirus (COVID-19) in the general population.

Oxford COVID-19 vaccine begins human trial stage

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine.

Natural mood regulation low or even absent in people with depression

Periods of lockdown during the COVID-19 situation likely to exacerbate problems with mood regulation, say experts at the University of Oxford.

Universities into the Breach

9 Apr 2020 Professor Louise Richardson, Vice-Chancellor of the University of Oxford, explores the international response to Covid-19 and the role of universities, who are working with colleagues across the globe to understand the disease and protect our communities.

New study to explore the effects of social distancing launched online

Researchers at the University of Oxford are looking for volunteers from across the globe to take part in a new study looking into how social distancing has affected their lives during the Covid-19 pandemic. Volunteers can complete the online survey, which will track people's feelings and experiences over a 3-month period.

Five Oxford COVID-19 projects receive UKRI funding

Five projects from across Oxford University's Medical Sciences Division are amongst twenty-one new studies into the novel coronavirus which have been funded by the UK government.

Load More